Annual SGA
$178.05 M
+$16.29 M+10.07%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual SGA is $178.05 million, with the most recent change of +$16.29 million (+10.07%) on December 31, 2023.
- During the last 3 years, VIR annual SGA has risen by +$107.11 million (+151.00%).
- VIR annual SGA is now at all-time high.
Performance
VIR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$25.74 M
-$4.52 M-14.94%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly SGA is $25.74 million, with the most recent change of -$4.52 million (-14.94%) on September 30, 2024.
- Over the past year, VIR quarterly SGA has dropped by -$4.52 million (-14.94%).
- VIR quarterly SGA is now -53.84% below its all-time high of $55.78 million, reached on December 31, 2021.
Performance
VIR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.64 B
-$533.34 M-48.30%
September 30, 2024
Summary
- As of February 7, 2025, VIR TTM SGA is -$1.64 billion, with the most recent change of -$533.34 million (-48.30%) on September 30, 2024.
- Over the past year, VIR TTM SGA has dropped by -$1.79 billion (-1175.27%).
- VIR TTM SGA is now -206.36% below its all-time high of $1.54 billion.
Performance
VIR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VIR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.1% | -14.9% | -1175.3% |
| 3 y3 years | +151.0% | -45.0% | -1061.7% |
| 5 y5 years | +511.2% | -45.0% | -1061.7% |
VIR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.7% | -53.8% | at low | -206.4% | +32.1% |
| 5 y | 5-year | at high | +373.6% | -53.8% | +118.0% | -206.4% | +44.3% |
| alltime | all time | at high | +720.8% | -53.8% | +248.2% | -206.4% | +44.3% |
Vir Biotechnology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $25.74 M(-14.9%) | $137.11 M(-10.0%) |
| Jun 2024 | - | $30.27 M(-16.6%) | $152.30 M(-9.1%) |
| Mar 2024 | - | $36.27 M(-19.1%) | $167.54 M(-5.9%) |
| Dec 2023 | $178.05 M(+10.1%) | $44.83 M(+9.5%) | $178.05 M(+3.5%) |
| Sep 2023 | - | $40.93 M(-10.1%) | $171.97 M(-1.3%) |
| Jun 2023 | - | $45.51 M(-2.7%) | $174.21 M(+2.3%) |
| Mar 2023 | - | $46.78 M(+20.7%) | $170.28 M(+5.3%) |
| Dec 2022 | $161.76 M(+0.6%) | $38.74 M(-10.3%) | $161.76 M(-9.5%) |
| Sep 2022 | - | $43.17 M(+3.8%) | $178.80 M(-3.9%) |
| Jun 2022 | - | $41.59 M(+8.7%) | $186.12 M(+7.4%) |
| Mar 2022 | - | $38.26 M(-31.4%) | $173.31 M(+7.8%) |
| Dec 2021 | $160.79 M | $55.78 M(+10.5%) | $160.79 M(+25.6%) |
| Sep 2021 | - | $50.50 M(+75.4%) | $128.06 M(+32.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $28.78 M(+11.8%) | $96.42 M(+14.8%) |
| Mar 2021 | - | $25.74 M(+11.7%) | $84.03 M(+18.5%) |
| Dec 2020 | $70.94 M(+88.7%) | $23.04 M(+22.2%) | $70.94 M(+18.8%) |
| Sep 2020 | - | $18.86 M(+15.1%) | $59.70 M(+19.3%) |
| Jun 2020 | - | $16.39 M(+29.5%) | $50.06 M(+20.1%) |
| Mar 2020 | - | $12.65 M(+7.1%) | $41.69 M(+10.9%) |
| Dec 2019 | $37.60 M(+29.1%) | $11.81 M(+28.1%) | $37.60 M(+11.4%) |
| Sep 2019 | - | $9.22 M(+15.1%) | $33.74 M(+5.7%) |
| Jun 2019 | - | $8.01 M(-6.4%) | $31.91 M(+33.5%) |
| Mar 2019 | - | $8.56 M(+7.7%) | $23.90 M(+55.8%) |
| Dec 2018 | $29.13 M(+34.3%) | $7.95 M(+7.5%) | $15.34 M(+107.5%) |
| Sep 2018 | - | $7.39 M | $7.39 M |
| Dec 2017 | $21.69 M | - | - |
FAQ
- What is Vir Biotechnology annual SGA?
- What is the all time high annual SGA for Vir Biotechnology?
- What is Vir Biotechnology annual SGA year-on-year change?
- What is Vir Biotechnology quarterly SGA?
- What is the all time high quarterly SGA for Vir Biotechnology?
- What is Vir Biotechnology quarterly SGA year-on-year change?
- What is Vir Biotechnology TTM SGA?
- What is the all time high TTM SGA for Vir Biotechnology?
- What is Vir Biotechnology TTM SGA year-on-year change?
What is Vir Biotechnology annual SGA?
The current annual SGA of VIR is $178.05 M
What is the all time high annual SGA for Vir Biotechnology?
Vir Biotechnology all-time high annual SGA is $178.05 M
What is Vir Biotechnology annual SGA year-on-year change?
Over the past year, VIR annual SGA has changed by +$16.29 M (+10.07%)
What is Vir Biotechnology quarterly SGA?
The current quarterly SGA of VIR is $25.74 M
What is the all time high quarterly SGA for Vir Biotechnology?
Vir Biotechnology all-time high quarterly SGA is $55.78 M
What is Vir Biotechnology quarterly SGA year-on-year change?
Over the past year, VIR quarterly SGA has changed by -$4.52 M (-14.94%)
What is Vir Biotechnology TTM SGA?
The current TTM SGA of VIR is -$1.64 B
What is the all time high TTM SGA for Vir Biotechnology?
Vir Biotechnology all-time high TTM SGA is $1.54 B
What is Vir Biotechnology TTM SGA year-on-year change?
Over the past year, VIR TTM SGA has changed by -$1.79 B (-1175.27%)